HCPCS Level II
J9305
Injection, pemetrexed, not otherwise specified, 10 mg
Codes near J9305
These sit next to J9305 in the CMS Level II file. All J codes
- J9300Injection, gemtuzumab ozogamicin, 5 mg
- J9301Injection, obinutuzumab, 10 mg
- J9302Injection, ofatumumab, 10 mg
- J9303Injection, panitumumab, 10 mg
- J9304Injection, pemetrexed (pemfexy), 10 mg
- J9306Injection, pertuzumab, 1 mg
- J9307Injection, pralatrexate, 1 mg
- J9308Injection, ramucirumab, 5 mg
- J9309Injection, polatuzumab vedotin-piiq, 1 mg
- J9310Injection, rituximab, 100 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00002-7623-01 | Alimta | Eli Lilly and Company | 50 |
| 00002-7640-01 | Alimta | Eli Lilly and Company | 10 |
| 25021-0260-10 | Pemetrexed | Sagent Pharmaceuticals | 10 |
| 25021-0261-50 | Pemetrexed | Sagent Pharmaceuticals | 50 |
| 43598-0370-74 | Pemetrexed | Dr. Reddy's Laboratories Inc. | 100 |
| 43598-0386-62 | Pemetrexed | Dr. Reddy's Laboratories Inc. | 10 |
| 43598-0387-11 | Pemetrexed | Dr. Reddy's Laboratories Inc. | 50 |
| 50742-0341-01 | Pemetrexed | Ingenus Pharmaceuticals LLC | 50 |
| 55150-0381-01 | Pemetrexed | Eugia US LLC | 10 |
| 55150-0382-01 | Pemetrexed | Eugia US LLC | 50 |
| 55150-0383-01 | Pemetrexed | Eugia US LLC | 100 |
| 60505-6065-00 | Pemetrexed | Apotex Corp | 10 |
| 60505-6066-00 | Pemetrexed | Apotex Corp | 50 |
| 60505-6067-00 | Pemetrexed | Apotex Corp | 100 |
| 60505-6068-00 | Pemetrexed | Apotex Corp | 75 |
| 63323-0134-10 | Pemetrexed | FreseniUS Kabi USA, LLC | 10 |
| 63323-0450-50 | Pemetrexed | FreseniUS Kabi USA, LLC | 50 |
| 68001-0535-41 | Pemetrexed | BluePoint Laboratories | 10 |
| 68001-0536-41 | Pemetrexed | BluePoint Laboratories | 50 |
| 68001-0538-41 | Pemetrexed | BluePoint Laboratories | 10 |
| 68001-0539-41 | Pemetrexed | BluePoint Laboratories | 50 |
| 68001-0543-41 | Pemetrexed | BluePoint Laboratories | 10 |
| 68001-0544-41 | Pemetrexed | BluePoint Laboratories | 50 |
| 68001-0545-41 | Pemetrexed | BluePoint Laboratories | 75 |
| 68001-0546-41 | Pemetrexed | BluePoint Laboratories | 100 |
| 70069-0834-01 | Pemetrexed | Somerset Pharma, LLC | 10 |
| 70069-0835-01 | Pemetrexed | Somerset Pharma, LLC | 50 |
| 70710-1654-01 | Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 10 |
| 70710-1655-01 | Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 50 |
| 70710-1674-01 | Pemetrexed | Zydus Pharmaceuticals (USA) Inc. | 100 |
| 70860-0202-10 | Pemetrexed | Athenex Pharmaceutical Division, LLC | 10 |
| 70860-0203-50 | Pemetrexed | Athenex Pharmaceutical Division, LLC | 50 |
| 71288-0147-50 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 75 |
| 71288-0148-51 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 100 |
| 71288-0166-10 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 10 |
| 71288-0166-91 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 10 |
| 71288-0166-92 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 10 |
| 71288-0167-50 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 50 |
| 71288-0167-95 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 50 |
| 71288-0167-96 | Pemetrexed | Meitheal Pharmaceuticals Inc. | 50 |
| 72603-0325-01 | Pemetrexed | Northstar RxLLC | 10 |
| 72603-0425-01 | Pemetrexed | Northstar RxLLC | 50 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.